CD24 is a Novel Blood Biomarker for the Early Detection of Colorectal Adenomas and Adenocarcinomas

被引:0
|
作者
Kraus, Sarah
Naumov, Inna
Kazanov, Diana
Galazan, Lior
Shapira, Shiran
Lisiansky, Victoria
Aroch, Ilan
Geva, Ravit
Shacham-Shmueli, Einat
Hallak, Aharon
Shafat, Itay
Kastrinos, Fay
Neugut, Alfred I.
Arber, Nadir
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
S1119
引用
收藏
页码:S184 / S184
页数:1
相关论文
共 50 条
  • [21] CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancer
    Ahmed, M. A. H.
    Al-Attar, A.
    Kim, J.
    Watson, N. F. S.
    Scholefield, J. H.
    Durrant, L. G.
    Ilyas, M.
    JOURNAL OF CLINICAL PATHOLOGY, 2009, 62 (12) : 1117 - 1122
  • [22] Epigenetic control of CD24 expression in colorectal cancer
    Ayub, M.
    Bodmer, W.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S30 - S30
  • [23] CD24 is a new oncogene, early at the multistep process-of colorectal cancer carcinogenesis
    Sagiv, Eyal
    Memeo, Lorenzo
    Karin, Adi
    Kazanov, Diana
    Jacob-Hirsch, Jasmin
    Mansukhani, Mahesh
    Rechavi, Gidi
    Hibshoosh, Hanina
    Arber, Nadir
    GASTROENTEROLOGY, 2006, 131 (02) : 630 - 639
  • [24] The dark age of single organ screening is over: CD24 is a novel universal pan-cancer blood test for early detection of cancer
    Madah, Fatin
    Kazanov, Dina
    Motlaq, Mays
    Argaman, Lihi
    Shaked, Meital
    Shenberg, Gil
    Hofman, Yael
    Sror, Miri
    Peer, Michael
    Greissaro, Dan
    Tepper, Michael
    Ben-Shimon, Marina
    Galazan, Lior
    Wolf, Ido
    Shapira, Shiran
    Arber, Nadir
    CANCER RESEARCH, 2023, 83 (07)
  • [25] CD24 is a biomarker for prognosis and therapeutic target in bladder cancer
    Smith, SC
    Nitz, MD
    Frierson, HF
    Theodorescu, D
    LABORATORY INVESTIGATION, 2006, 86 : 162A - 162A
  • [26] CD24 in Head and Neck Malignancies-An Uprising Biomarker?
    Neiderman, Narin N. Carmel
    Shapira, Shiran
    Klein, Linor
    Rafael, Dor
    Gorelik, Gregory
    Kampel, Liyona
    Arber, Nadir
    Muhanna, Nidal
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (12):
  • [27] CD24 is a Potential Biomarker for Prognosis in Human Breast Carcinoma
    Jing, Xuan
    Cui, Xiangrong
    Liang, Hongping
    Hao, Chonghua
    Yang, Zhining
    Li, Xiaogai
    Yang, Xiaojuan
    Han, Chongyang
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 48 (01) : 111 - 119
  • [28] THE DARK AGE OF SINGLE ORGAN SCREENING IS OVER: CD24 IS A NOVEL UNIVERSAL PAN-CANCER BLOOD TEST FOR EARLY DETECTION OF CANCER
    Mdah, Fatin
    Kazanov, Dina
    Motlaq, Mays
    Argaman, Lihi
    Shaked, Meital
    Shenberg, Gil
    Hoffman, Yael
    Sror, Miri
    Peer, Michael
    Grisaru, Dan
    Tepper, Michael
    Ben-Shimon, Marina
    Galazan, Lior
    Wolf, Ido
    Shapira, Shiran
    Arber, Nadir
    GASTROENTEROLOGY, 2023, 164 (06) : S991 - S991
  • [29] THE DARK AGE OF SINGLE ORGAN SCREENING IS OVER: CD24 IS A NOVEL UNIVERSAL PAN-CANCER BLOOD TEST FOR EARLY DETECTION OF CANCER
    Shapira, Shiran
    Kazanov, Dina
    Ben Shimon, Marina
    Mdah, Fatin
    Levy, Mori Hay
    Galazan, Lior
    Ben Itzhak, Michal B.
    Gluck, Nathan
    Shaked, Meital
    Geva, Ravit B.
    Wolf, Ido
    Arber, Nadir
    GASTROENTEROLOGY, 2021, 160 (06) : S130 - S130
  • [30] The role of CD24 as a potential biomarker for malignant pleural mesothelioma
    Mousa, Mohamed Shaaban
    Ghoname, Ahmed Mamdooh
    Ateya, Dalia Abd El-Kareem
    Abdallah, Hamed A. H.
    Ahmed, Salwa Hassan
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2023, 72 (04): : 522 - 527